Live Breaking News & Updates on Prnewswire Triumvira Immunologics

Stay updated with breaking news from Prnewswire triumvira immunologics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Latest Updates of Viva's Portfolio Companies

/PRNewswire/ Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies long-term. ....

United States , Al Iskandariyah , San Diego , South San Francisco , Viva Bioinnovator , Prnewswire Triumvira Immunologics , Detlev Biniszkiewicz , John Mumm , Deka Biosciences , Huya Bio , Triumvira Immunologics , Genhouse Bio , Arthrosi Therapeutics Inc , Strategic Research Collaboration , Triumvira Immunologics Inc , Bioshanghai Biopharmaceutical Industry Investment Forum , Amacathera Inc , Industry Forum , Boehringer Ingelheim , Astellas Pharma Inc , Trial Using Dual Energy Computed Tomography , Xyphos Biosciences Inc , Acelink Therapeutics Inc , American College Of Rheumatology , Capital Women In Technology Venture Fund , Enters Strategic Collaboration ,

Latest Updates of 9 Viva's Portfolio Companies

/PRNewswire/ Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies long-term. ....

Dana Farber Cancer Institute , United States , South San Francisco , Prnewswire Triumvira Immunologics , Paddlehelix Helix , Genhouse Bio , Aixplorerbio Aixmol , Benjaminl Schlechter , Viva Bioinnovator , Triumvira Immunologics , Baidu Paddlehelix , Mining Research , Triumvira Immunologics Inc , International Biomedical Innovation Competition , Technoderma Medicines Inc , Fuse Biotherapeutics Inc , Harvard Medical School , Boston Chinese Investment Association , Haiwang Alliance , American Society , Present Phase , Clinical Trial , Society Of Clinical Oncology , Annual Meeting , Senior Physician , Gastrointestinal Oncology ,

Triumvira Immunologics Highlights Positive Phase 1 Clinical Data on TAC01-HER2 in Solid Tumors at ASCO 2023 Annual Meeting

/PRNewswire/ Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the. ....

United States , South San Francisco , Deyaa Adib , Prnewswire Triumvira Immunologics , David Schull , Benjaminl Schlechter , Benjamin Schlechter , Ignacio Guerrero Ros , Triumvira Immunologics , Dana Farber Cancer Institute , Harvard Medical School , American Society , Triumvira Immunologics Inc , Society Of Clinical Oncology , Annual Meeting , Senior Physician , Gastrointestinal Oncology , Chief Medical Officer , Principal Investigator , Investigating Safety , Refractory Solid Tumors , Attending Physician , Medical Oncology , Dana Farber Cancer , Developmental Therapeutics , Session Display Date ,

Triumvira Immunologics to Present Clinical Data from Phase I/II Trial TACTIC-2 Investigating TAC01-HER2 at the 2023 ASCO Annual Meeting

/PRNewswire/ Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the. ....

United States , South San Francisco , Prnewswire Triumvira Immunologics , Ignacio Guerrero Ros , Benjaminl Schlechter , Triumvira Immunologics , Deyaa Adib , Dana Farber Cancer Institute , Harvard Medical School , American Society , Triumvira Immunologics Inc , Society Of Clinical Oncology , Annual Meeting , Senior Physician , Gastrointestinal Oncology , Chief Medical Officer , Investigating Safety , Refractory Solid Tumors , Attending Physician , Medical Oncology , Dana Farber Cancer , Developmental Therapeutics , Session Display Date , Discussion Session Date , Antigen Coupler ,

Triumvira Immunologics Establishes Collaboration with Merck to Evaluate TAC01-HER2 Cell Therapy in Combination with KEYTRUDA® (pembrolizumab) in Patients with HER2-positive Solid Tumors

/PRNewswire/ Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the. ....

United States , South San Francisco , Paul Lammers , Deyaa Adib , Ignacio Guerrero Ros , Prnewswire Triumvira Immunologics , Triumvira Immunologics , Merck Co Inc , Merck Sharp Dohme , Development Committee , European Society For Medical Oncology , Triumvira Immunologics Inc , Chief Executive Officer , European Society , Medical Oncology , Chief Medical Officer , Joint Development Committee , Merck Sharp , Antigen Coupler ,